Now I have a solid comparative picture. Let me finalize the review.

**Round 1 bracket:** 5.5–7.0

**Round 2 anchors and comparisons:**
- CHEMGUIDE (6.00): Uses non-differentiable oracles for diffusion guidance. Our paper is clearly stronger — more consistent empirical gains across 3 backbones vs. 1, better formalized theory, cleaner method.
- SyCO/Lift Your Molecules (6.50): Novel latent-space framework for molecular graph generation. Experimental ambiguity about whether the inductive bias helps. Our paper has stronger, less ambiguous empirical results.
- DrugFlow (6.67): Multi-domain flow matching for SBDD with several features. Has more breadth but technical soundness concerns and unclear performance advantages. Our paper is more focused with cleaner validation.
- UniGEM (6.67): Unified generation + prediction. Marginal improvements over baselines, insufficient baselines. Our paper shows more substantial and consistent gains.
- GeoBFN (8.00): More complete, polished contribution with SOTA results. Our paper is below this tier.

**Final score:** 6.5 — The paper makes a genuine contribution (DC-structure formalization, DIST method) with strong, consistent empirical validation across diverse backbones. The weaknesses (scoring function deferred to appendix, incomplete cost accounting formula) are real but addressable and do not undermine core claims.

---

## Summary

This paper identifies and formalizes a structural challenge in diffusion-based 3D molecular generation: molecular data distributions exhibit a "dense-concentrated structure" (DC-structure) — narrow, densely packed probability peaks separated by near-zero-density regions — which causes standard reverse diffusion to overshoot valid peaks and accumulate irrecoverable errors. The authors propose DIST, a plug-in corrective method that, at an intermediate timestep, filters trajectories by running pilot inferences and discarding those leading to invalid molecules, thereby realigning the model distribution with the true data distribution. Experiments across three architecturally diverse backbones (EDM, GeoLDM, RADM) on QM9 and GEOM-Drugs show consistent and substantial improvements in molecule stability, validity, and atom stability, while also reducing inference timesteps.

## Strengths

- **Novel formalization of the DC-structure problem**: Definition 3.1 provides a quantitative framework characterizing molecular distributions in terms of peak width (σ*), separation (Δ), and concentration (δ_t). The overshoot analysis in Eqs. 6–7 directly derives from this definition, showing concretely that when σ* is small, reverse step magnitudes can exceed peak radii, pushing samples into invalid low-density regions. This formalization goes beyond vague claims and gives the paper analytical traction.

- **Strong, consistent empirical gains across architecturally diverse backbones**: Table 2 demonstrates that DIST improves all three backbone models — EDM (GNN-based equivariant, coordinate-space), GeoLDM (latent-space diffusion), and RADM (Transformer-based non-equivariant, latent-space) — on both QM9 and GEOM-Drugs across all metrics. EDM+DIST raises molecule stability from 82.0% to 89.9% (+7.9pp) and validity from 91.9% to 96.9% (+5.0pp). The universality of gains across fundamentally different architectures provides compelling evidence that the DC-structure problem is architecture-independent and that DIST's trajectory-correction mechanism genuinely addresses it.

- **Informative diagnostic experiment**: Table 1 demonstrates monotonic degradation in molecule quality as the starting timestep increases from t=0 (95.2% mol stability) to t=1000 (82.0%), directly validating the error-accumulation narrative that motivates DIST's intermediate correction.

- **Well-executed ablation study**: Table 4 shows that DIST's improvements are robust to the pilot sample budget — even 30 pilot samples (428.3 timesteps) substantially outperform the EDM baseline (82.0% mol stability at 1000 timesteps) — and that quality scales monotonically with budget, as expected.

## Weaknesses

### Fatal

None.

### Major

- **The scoring function — the core filtering mechanism — is underspecified in the main text**: Section 3.2 lists possible scoring functions (e.g., round-trip residual, self-consistency, ensemble variance, chemistry-based penalty) without stating which is actually used (line 150). The corrective sampling paragraph (lines 176–177) describes running full pilot inference to evaluate trajectory alignment, which implies a chemistry-based validity/stability check, but the exact scoring function, the threshold τ, and how they are computed are deferred to Appendix F. Since the entire filtering step depends on this score, the method description in the main text is incomplete. Readers cannot fully evaluate what DIST is doing without the appendix. This should be addressed in rebuttal by stating the scoring function and threshold explicitly in the main text.

- **Cost accounting formula in the main text is incomplete**: The formula on line 221 — (T−t)/|B| + t — only accounts for denoising steps along accepted trajectories. It does not explicitly discuss the cost of pilot inference (full t→0 reverse simulation on pilot subsets), the cost of generating candidates that populate rejected batches, or the cost of entirely discarded batches. While Table 3 reports average timesteps computed from total consumption, the formula presented as the efficiency justification does not reconcile transparently with a full cost accounting. The paper claims DIST reduces computational cost "to nearly half" (abstract), but without a transparent breakdown, the efficiency claim is not fully substantiated in the main text.

### Minor

- **Theory and method run on parallel tracks**: Proposition 3.1 provides a general TV-error bound in terms of α(τ), β(τ), and conditional discrepancies, but the bound does not concretely guide the choice of τ, r, batch construction, or scoring function. Corollary 3.1 establishes that TV distance contracts under the ideal reverse kernel — a basic property. The theory provides conceptual motivation but does not meaningfully constrain or inform the practical method.

- **Missing standard deviations for GEOM-Drugs results**: Table 2 reports single numbers for GEOM-Drugs, unlike QM9 where standard deviations from three runs are given. For a stochastic generative process on a dataset of 420K molecules, single-point estimates are insufficient to assess significance of the reported improvements (e.g., EDM+DIST atom stability 82.2% vs. EDM 81.3%).

- **Key hyperparameters deferred to appendix**: The intermediate timestep t, perturbation magnitude, and batch score threshold are first-order hyperparameters that control the quality–cost tradeoff. Their values and sensitivity are not discussed in the main text, making it harder to assess the method's practical deployment without the appendix.

### Trivial

- The paper claims to set "new state-of-the-art" (line 211) but the baselines in Table 2 are limited to EDM, GeoLDM, RADM, ENF, and G-SchNet. The scope of the SOTA claim relative to the breadth of recent molecular generation work is not fully contextualized — though consistent improvement over strong baselines is itself a solid contribution.

## Nice-to-Haves

- An ablation comparing the actual scoring function against cheaper alternatives (e.g., ensemble variance at the intermediate timestep rather than full pilot inference) would strengthen the case that full pilot inference is necessary.
- Connecting the theory to the method more concretely — e.g., deriving a practical guideline for choosing τ from the bound in Proposition 3.1 — would elevate the theoretical contribution beyond conceptual motivation.
- Reporting total FLOPs or model forward passes per accepted molecule alongside timestep counts would give a more complete picture of efficiency.

## Removed Points

These points are flagged to be removed, treat them with caution:

- **Harsh Critic claimed the scoring function is "never specified"**: The corrective sampling paragraph (lines 176–177) does describe the mechanism — full reverse inference on pilot subsets, evaluation of pilot outcomes, filtering. The exact formula is deferred to Appendix F, which is a specification-location issue (kept as Major), not a complete omission.

- **Harsh Critic claimed efficiency claim is not supported by any evidence**: Table 3 does report total timestep consumption, which constitutes evidence. The issue is that the formula in the text doesn't reconcile with a full accounting (kept as Major).

- **Harsh Critic noted Table 1 uses clean-data initialization rather than model distribution**: The experiment is explicitly described as forming z_t ~ p(z_t|x) and then running t reverse steps. It still validly demonstrates error accumulation, which is the point the authors use it for.

- **Harsh Critic claimed DIST is not "first to highlight" DC-structure**: This is a novelty-claim positioning concern that requires external literature knowledge to verify. The paper does discuss related latent-space and architectural approaches (Sec. 2.2).

- **Harsh Critic noted Appendix B comparison is missing from main text**: The paper explicitly references Appendix B (line 76). Deferring a detailed related-work comparison to the appendix is a presentation choice, not a weakness.

- **Strength Finder claimed efficiency gains as a standalone strength**: The efficiency story is entangled with the cost-accounting concern. The quality improvements are the stronger and more robust story.

- **Strength Finder claimed "theoretical justification for intermediate correction" as a strength**: While Corollary 3.1 and Proposition 3.1 provide theoretical framing, the theory-method gap limits their impact beyond conceptual motivation.

## Novel Insights

The paper's formalization of the DC-structure (Definition 3.1) and the accompanying overshoot analysis (Eqs. 6–7) provide a genuinely useful lens for understanding why diffusion models struggle with highly constrained distributions — not just in molecules but potentially in any domain with narrow, well-separated valid regions (proteins, mechanical designs, etc.). The insight that the problem is not just about score estimation error but about the interaction between peak geometry and discretized reverse dynamics is novel and well-articulated.

## Suggestions

- In the main text, explicitly state the scoring function (e.g., "molecule validity of pilot-generated structures") and the threshold used. A one-sentence specification would resolve the major underspecification concern.
- Reconcile the efficiency formula with Table 3 numbers — either show how the formula accounts for all costs including pilots and rejections, or provide a complete cost breakdown.
- Add standard deviations to the GEOM-Drugs results in Table 2.
- Move the intermediate timestep t value and its selection rationale into the main text (even one sentence).

---

**Calibration anchors summary:**

| Anchor | Score | Round | Comparison |
|--------|-------|-------|------------|
| DynamicsDiffusion (kKXIYUi8ff) | 3.00 | R1-low | Our paper is substantially stronger in motivation, theory, and empirical validation |
| PsiDiff (m9zWBn1Y2j) | 3.00 | R1-low | Our paper has clearer contribution and stronger results |
| TorSeq (G536mmC2HL) | 3.00 | R1-low | Our paper has more novelty and better empirical evidence |
| MoreRed (rwmWd2rjP1) | 4.75 | R1-mid | Our paper has broader scope and more consistent gains |
| EQGAT-diff (kzGuiRXZrQ) | 5.75 | R1-mid | Our paper has more novelty (DC-structure) and similarly strong empirical results |
| CHEMGUIDE (4dAgG8ma3B) | 6.00 | R2-low | Our paper is stronger — more consistent gains across more backbones, better theory |
| VFDiff (5YLsnsjgeC) | 6.00 | R1/R2 | Our paper has cleaner, more universal plug-in method |
| SyCO/Lift Your Molecules (uNomADvF3s) | 6.50 | R1-mid | Comparable quality; our paper has less ambiguous empirical evidence |
| DrugFlow (g3VCIM94ke) | 6.67 | R2-high | DrugFlow has more breadth but technical concerns; our paper is more focused |
| UniGEM (Lb91pXwZMR) | 6.67 | R2-high | UniGEM has marginal improvements; our gains are more substantial |
| GeoBFN (NSVtmmzeRB) | 8.00 | R1-high | Our paper is clearly below — less polished, less complete |
| FoldFlow (kJFIH23hXb) | 8.00 | R1-high | Our paper is clearly below — narrower scope, specification issues |

**Bracket:** Round 1 placed the paper between 5.5 and 7.0. Round 2 narrowed this to 6.0–6.5: the paper is clearly stronger than the 6.0 anchors (CHEMGUIDE, VFDiff) and comparable to or slightly below the 6.5–6.67 anchors (SyCO, DrugFlow, UniGEM). The paper's consistent, substantial empirical gains across diverse backbones are its strongest asset; the specification deferral and cost-accounting clarity are its main drag.

MY FINAL SCORE: <score>6.5</score>
MY FINAL DECISION: <decision>Accept</decision>